Allergan pursuers get expedited trial over special meeting date

Delaware Court of Chancery Chancellor Andre Bouchard orders a three-day trial to begin October 6, 2014 to settle the issue of the timing of the Allergan (AGN -0.8%) special shareholders meeting sought by Valeant Pharmaceuticals (VRX -0.8%) and Pershing Square Capital Management. Allergan scheduled the meeting for December 18, 2014 but its pursuers wanted mid-November so they filed suit to resolve the issue. Unsurprisingly, Allergan wanted the trial to start later. It preferred a November 24 start.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs